Trump#39;s #39;Buy American#39; order for essential drugs may have limited impact on Indian pharma companies

India#39;s contribution to the $65-$70 billion US generics market is only about 10 percent, says pharma trade body Pharmexcil, and the cost of production here is 40 percent lower than in North America and Europe